Sort   by:  
 Page size 
UnknownPertuzumab, trastuzumab, and docetaxel in HER2-positive metastatic breast cancer.
Not available
S-EPMC5584549 | biostudies-literature
UnknownPertuzumab plus trastuzumab plus docetaxel for metastatic breast cancer.
Not available
S-EPMC5705202 | biostudies-literature
UnknownClonal Evolution and Blast Crisis Correlate with Enhanced Proteolytic Activity of Separase in BCR-ABL b3a2 Fusion Type CML under Imatinib Therapy.
Not available
S-EPMC4472749 | biostudies-literature
UnknownOlder patients with chronic myeloid leukemia (≥65 years) profit more from higher imatinib doses than younger patients: a subanalysis of the randomized CML-Study IV.
Not available
S-EPMC4050299 | biostudies-literature
Sort   by:  
 Page size